2026 Global Pharmaceutical Innovation and Invention Index
The annual ranking of the world’s leading pharma companies by their ability to create new ideas and turn them into […]
Eli Lilly top 2026 Global Pharmaceutical Innovation & Invention Index
Eli Lilly First Ever Company to Top Both Rankings in the 2026 Pharmaceutical Innovation and Invention Index See the full results at https://www.ideapharma.com/pii/report/global/ LONDON, UK — May 19th 2026 — The 2026 Global Pharmaceutical Innovation
2026 Freshness Index
The Freshness Index shows the percentage of company sales generated by products launched in the last three and five years.
IDEA Pharma is a proud partner of Candel Therapeutics
Through an integrated partnership with EVERSANA and CANDEL, we are helping to change patient lives by maximizing the potential of aglatimagene besadenovec to raise the standards
Creating the Right Answer: The Fulcrum EVOLVE™ Framework for Pharmaceutical Positioning
Creating the Right Answer: The Fulcrum EVOLVE™ Framework for Pharmaceutical Positioning Introduction: The Wrong Question Pharmaceutical market research is often
Positioning Matters – from IDEA Pharma
In Pharmaceutical Positioning, the challenge is to find the perfect combination of what the medical environment needs (even if your
The Modern Patient Experience: How AI and Expanded Stakeholder Perspectives Are Transforming Rare Disease Patient Journey Research
The Rare Disease Journey Is More Complex Than Ever Rare disease patient journeys have always been difficult to navigate. Today,
A New Frontier: Leveraging Synthetic Users in Pharmaceutical Market Research
The pharmaceutical industry increasingly relies on sophisticated market research to understand healthcare professionals, patients, and stakeholders. However, traditional research methods—while
IDEA Pharma – Vyvanse Positioning Case Study
IDEA Pharma work with Biopharma from early through late phase development to deliver best-in-class positioning and path-to-market strategy. The IDEA Pharma
Building the In Vivo Future: What Lilly’s Kelonia Bet Really Signals
By Amith Chordia and John Barry. Eli Lilly’s recent acquisition of Kelonia raised eyebrows, not because of what’s proven, but